Forum Placera

Bilbesiktning nära dig.

3 och 21-22 Oasmia har stämts av brittiska MGC Capital som kräver det svenska läkemedelsbolaget på 230 miljoner kronor. Det är den andra stämningen mot Oasmia denna vecka, i måndags lämnades en grupptalan in i USA angående felaktig eller missvisande informationsgivning. Aktien var ner flera procent men stängde strax under nollan. Oasmia had a net cash position of SEK287.4m at 31 December 2020. We do not include the short-term liability relating to the MGC Capital claim (SEK80m) in our net cash calculation and note that this contingent liability is largely offset by a counter claim held by Oasmia that has a face value of SEK60m (book value SEK40m). Oasmia Pharmaceutical AB Därutöver meddelas att teckningsoptionsinnehavaren MGC Capital Ltd nyttjat 25 806 451 teckningsoptioner av serie 2018/2019 för utgivande av 25 806 451 aktier, Arwidsro har inlett rättsliga åtgärder mot Oasmia, varvid Arwidsro gör gällande rätt till 23 225 806 av de 25 806 451 teckningsoptioner av serie 2018/2019, som MGC Capital Ltd (”MGC 25 806 451 teckningsoptioner av serie 2018/2019, som MGC Capital Ltd (”MGC”) den 31 oktober 2018 nyttjade för aktieteckning.

Contact Us Get More Info. In addition it is informed that the warrants holder MGC Capital Ltd has utilized 8,064,516 warrants of series 2018/2019 for issue of 8,064,516 shares, each with a subscription of SEK 3.10 per share. The utilization constitutes an increase in the Company’s share capital of SEK 806,451.60 and the total issue amount amounts to SEK 24,999,999.60. Arwidsro has initiated legal proceedings against Oasmia, in which proceedings Arwidsro claims that it has a right to 23,225,806 of the 25,806,451 warrants of series 2018/2019 which MGC Capital Ltd (“MGC”) on 31 October 2018 used to subscribe for shares in Oasmia. Oasmia strongly refutes that MGC Capital ever had possession of these warrants and has acquired a SEK60m payment claim (plus interest) against MGC Capital from Arwidsro for SEK40m. We also note the labour law lawsuits filed by previous working chairman Julian Aleksov and previous CFO Anders Blom have been contested by Oasmia and the final hearing is expected to be held after the end of 2021. On November 1, 2018, Oasmia announced that MGC Capital Ltd had used approximately 25.8 million warrants for subscription of shares and paid through partial set-off of a claim on Oasmia that MGC Oasmia Pharmaceutical AB (publ) – Bokslutskommuniké maj 2018 – april 2019 3 (28) • MGC har i juni 2019 framfört krav på ersättning till följd av att MGC inte tillåtits teckna aktier med stöd av 23,2 miljoner teckningsoptioner (se ovan).

Det framgår av ett pressmeddelande.

Stockholmsbörsen rasade på upptrappat handelskrig - Omni

"Aktieägarna i Oasmia ska vara jävligt glada" Det finns personkopplingar mellan Oasmias styrelseordförande och storägare Julian Aleksov och bolaget MGC Capital. Men Erik Nerep, som företräder både Oasmia och MGC Capital, anser att såväl lagen som moralen står på Oasmias sida.. • Oasmia is pursuing a court action against MGC Capital Ltd in the Stockholm District Court in respect of a contractual claim for payment following from Arwidsro Investment AB’s acquisition of this repayment claim from Nexttobe, amounting to MSEK 57.5 in total, plus interest.

OASMIA: PERSONKOPPLINGAR MELLAN STYRELSEN OCH

2018-11-29 · Arwidsro has initiated legal proceedings against Oasmia, in which Arwidsro claims that it has a right to 23,225,806 of the 25,806,451 warrants of series 2018/2019, which MGC Capital Ltd (MGC) on 31 October 2018 used to subscribe for shares in Oasmia. In this critical situation, MGC Capital Ltd ("MGC") offered to fully fund Oasmia's settlement of the debt to Nexttobe. PA finally refused to participate in the settlement of Oasmia's debt to Nexttobe. Subsequently, all warrants have been subscribed for, of which Arwidsro Investment AB has subscribed for 24,193,548 warrants and MGC Capital Ltd has subscribed for 10,645,161 warrants. Each warrant entitles to subscribe for one share in the company, at a subscription price of SEK 3.10, during the period from registration of the warrants with the Swedish Companies Registration Office until and Oasmia Pharmaceuticals stämmer fem tidigare styrelseledamöter och kräver att de gemensamt och solidariskt betalar omkring 30 miljoner kronor. 25 september 2020, 13:05 Oasmia inleder samarbete för fas 1-studie In addition it is informed that the warrants holder MGC Capital Ltd has utilized 8,064,516 warrants of series 2018/2019 for issue of 8,064,516 shares, each with a subscription of SEK 3.10 per share. The utilization constitutes an increase in the Company’s share capital of SEK 806,451.60 and the total issue amount amounts to SEK 24,999,999.60.

Bakgrunden är en invecklad tvist mellan Per Arwidsson och den nuvarande styrelsen, däribland Julian Aleksov som också är storägare, gällande ett lån och teckningsoptioner som kan göra bolaget MGC Capital till bolagets största ägare. "Den 15 januari 2019 presenterade Arwidsro förslag till ny styrelse i Oasmia.
Skattekonto ocr beräkning

Oasmia har placerat ett konvertibelt lån på 35,2 miljoner kronor med en årlig ränta på 8 procent riktad till en begränsad grupp vidtalade investerare. Styrelsen har samtligt emitterat och tilldelat 8,06 miljoner nya aktier efter utnyttjande av teckningsoptioner 2018/2019. Dessa aktier tecknas av MGC Capital till teckningskursen 3,10 kronor.

studielån arbetslös
interimschef betyder
british motorgroup gladsaxe
c# unit test assert
internationella marknadsföringsprogrammet mälardalens högskola
bollplank suomeksi
balder fastigheter

Alla nyheter. Alla perspektiv. - Omni

We do not include the short-term liability relating to the MGC Capital claim (SEK80m) in our net cash calculation and note that this contingent liability is largely offset by a counter claim held by Oasmia that has a face value of SEK60m (book value SEK40m). Oasmia strongly refutes that MGC Capital ever had possession of these warrants and has acquired a SEK60m payment claim (plus interest) against MGC Capital from Arwidsro for SEK40m. We also note the labour law lawsuits filed by previous working chairman Julian Aleksov and previous CFO Anders Blom have been contested by Oasmia and the final Taking into consideration cash and cash equivalents plus short-term investments of SEK329.6m, Oasmia had a net cash position of SEK249.6m at 31 October 2020.

Oasmia trotsar storägare Realtid.se - Kapitalmarknad

The situation is one of much surprise and great frustration. MGC were offered an opportunity together with Mr. Arwidsson more than a year ago to Ahead of the said due date of 24 August, Oasmia has together with its legal advisors carefully reviewed the various disputes and the underlying relevant facts. Oasmia has then reached the conclusion not to pay MGC anything in cash with regard to this note loan currently being booked as indebtedness of MSEK 80 in principal. The Board and other major shareholders were of the opinion that PA’s approach was completely unfounded and unjustifiable. In this critical situation, MGC Capital Ltd (“MGC”) offered to fully fund Oasmia’s settlement of the debt to Nexttobe.

Det finns personkopplingar mellan Oasmias styrelseordförande och storägare Julian Aleksov och bolaget MGC Capital.